Ursodeoxycholic acid therapy in recurrent or acquired genotype II hepatitis C virus infection after liver transplantation: a three-case report.
Kita
Y
Y
Department of Surgery II, Osaka University Medical School, Japan.
Beck
Y
Y
Teraoka
S
S
Yokota
K
K
Andoh
Y
Y
Nagao
T
T
Gotoh
M
M
Sakon
M
M
Monden
M
M
D000328:Adult; D005260:Female; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D005838:Genotype; D016174:Hepacivirus / Q000235:genetics*; D006509:Hepatitis B / Q000150:complications; D006526:Hepatitis C / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D008103:Liver Cirrhosis / Q000601:surgery* / Q000821:virology; D008111:Liver Function Tests; D016031:Liver Transplantation / Q000502:physiology; D008297:Male; D008875:Middle Aged; D012367:RNA, Viral / Q000032:analysis; D012008:Recurrence; D014580:Ursodeoxycholic Acid / Q000627:therapeutic use*
D005765:Gastrointestinal Agents; D012367:RNA, Viral; D014580:Ursodeoxycholic Acid